Imaging has long been central to cancer diagnosis and treatment. Today, however, clinicians and researchers are increasingly using imaging not only to locate tumours, but also to understand how they function, respond to treatment, and evolve over...
Latest News
Stay updated with the latest news from Cancer Core Europe! Discover advancements in cancer care, explore our consortium’s education and training initiatives, delve into our publications, meet our members, and much more.
Cancer Core Europe Continues Its Support for Early-Career Clinician-Scientists at the MCCR Workshop
Building on the success of last year’s initiative, the Cancer Core Europe (CCE) Clinical Trials and Translational Cancer Research Pillar, co-led by Prof. dr. Neeltje Steeghs (Netherlands Cancer Institute) and Dr. Richard Baird (Cancer Research...
CCE’s Virtual Data Centre (VDC): Advancing Precision Cancer Medicine through a Federated Data Ecosystem
Cancer Core Europe’s cross-border data sharing ecosystem in oncology makes data accessible to multiple applications, users, or organizations while ensuring that the sensitive parts of the data remain secure. It accelerates scientific progress by...
TRYTRAC: Building Careers in Cancer Research Through Mentorship and Innovation
TRYTRAC Fellows Gather in Milan for the Third In-Person Advanced Training Meeting Hosted by the Fondazione IRCCS Istituto Nazionale dei Tumori di Milan, the third in-person meeting of CCE’s TRYTRAC Advanced Training Program took place in Milan from May 21–23, 2026....
Shaping the Future of Cancer Research Through Education and Early-Career Engagement
Training the future leaders in translational cancer research and precision cancer medicine is central to CCE’s mission to advance precision oncology across Europe. With this goal in mind, the CCE Education & Training Pillar recently met at Karolinska Institutet in...
Gustave Roussy’s AI Ecosystem: From Clinical AI to Agentic Systems in Precision Oncology
How is artificial intelligence reshaping cancer care? In CCE’s lecture, Dr. Julien Vibert—oncologist and specialist in oncology drug development in the U1361 Cancer Data Science Unit (Inserm and Paris-Saclay University), PRISM National Precision...
Our commitment is to work on advanced cancer research for the benefit of patients
CANCER CORE EUROPE (CCE)













